Clinical Trials Browser

Glioma × atezolizumab × 90 days × Clear all

NCT04160494 2026-06-04

D2C7-IT With Atezolizumab for Recurrent Gliomas

Phase 1 Active not recruiting

Glioblastoma, Glioma